USA - NASDAQ:ACB - CA05156X8504 - Common Stock
ChartMill assigns a Buy % Consensus number of 73% to ACB. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-06-27 | Zuanic & Associates | Initiate | Neutral |
| 2023-06-16 | CIBC | Maintains | Neutral |
| 2023-06-15 | Canaccord Genuity | Maintains | Hold |
| 2022-09-21 | Piper Sandler | Maintains | Neutral |
| 2021-09-28 | MKM Partners | Upgrade | Sell -> Neutral |
| 2021-05-17 | Stifel Nicolaus | Downgrade | |
| 2021-05-17 | CIBC World Markets | Downgrade | |
| 2021-05-14 | Cowen | Downgrade | |
| 2021-05-14 | ATB Capital | Downgrade | Sector Perform -> Underperform |
| 2021-05-14 | MKM Partners | Downgrade | |
| 2021-05-14 | CIBC World Markets | Downgrade | Underperform |
| 2021-05-11 | CIBC World Markets | Downgrade | Neutral -> Underperform |
| 2021-02-24 | Jefferies | Upgrade | |
| 2021-02-16 | CIBC World Markets | Upgrade | Underperform |
| 2021-02-12 | ATB Capital | Upgrade | Sector Perform |
| 2021-02-12 | Stifel Nicolaus | Upgrade | |
| 2021-02-12 | MKM Partners | Reiterate | Sell |
| 2021-02-12 | Canaccord Genuity | Upgrade | |
| 2021-02-08 | CIBC World Markets | Upgrade |
9 analysts have analysed ACB and the average price target is 5.81 USD. This implies a price increase of 27.7% is expected in the next year compared to the current price of 4.55.
The consensus rating for AURORA CANNABIS INC (ACB) is 73.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering AURORA CANNABIS INC (ACB) is 9.